Pfizer Inc banner

Pfizer Inc
SGO:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
SGO:PFE
Watchlist
Price: 49.19 USD -0.36% Market Closed
Market Cap: $165.2B

Wall St Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 31.09 USD with a low forecast of 25.42 USD and a high forecast of 39.64 USD.

Lowest Forecast
Price Target
25.42 USD
48% Downside
Average Forecast
Price Target
31.09 USD
37% Downside
Highest Forecast
Price Target
39.64 USD
19% Downside
Pfizer Inc Competitors:
Price Targets
CIFR
Cipher Mining Inc
6% Upside
SYSR
Systemair AB
14% Upside
U10
UOB-Kay Hian Holdings Ltd
31% Upside

Revenue
Forecast

1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is -4%.

Gross Profit
Forecast

0% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
0% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is -4%.

Operating Income
Forecast

1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is -4%.

Pre-Tax Income
Forecast

-3% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-61%
Average Miss
-3% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-61%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 30%.

Net Income
Forecast

-5% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-55%
Average Miss
-5% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-55%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PFE's stock price target?
Price Target
31.09 USD

According to Wall Street analysts, the average 1-year price target for PFE is 31.09 USD with a low forecast of 25.42 USD and a high forecast of 39.64 USD.

What is the Revenue forecast for Pfizer Inc?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is -4%.

What is the Gross Profit forecast for Pfizer Inc?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is -4%.

What is the Operating Income forecast for Pfizer Inc?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is -4%.

What is the Pre-Tax Income forecast for Pfizer Inc?
Projected CAGR
30%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 30%.

What is the Net Income forecast for Pfizer Inc?
Projected CAGR
22%

Over the last 13 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett